Loading organizations...
§ Private Profile · Boulder, CO, USA
Agricultural biotech specializing in hemp and cannabis genetics breeding and mass-scale tissue culture for cultivators.
Based in Lafayette, Colorado, Front Range Biosciences is an agricultural biotechnology company that develops advanced hemp and cannabis genetics using proprietary tissue culture and breeding technologies. The organization provides mass-scale tissue culture propagation and improved plant varietals to cultivators operating within the commercial hemp and marijuana cultivation industries. By utilizing specialized nursery techniques, the enterprise focuses on reducing plant disease, physical space requirements, and manual labor costs typically associated with traditional cloning methods. Operating with a workforce of approximately 85 employees as of 2021, the firm has successfully raised $1.5 million in initial seed funding. This capital was secured through financial backing from a syndicate of institutional and angel investors, including investment groups such as Salveo Capital, Sand Hill Angels, and New York Angels. Front Range Biosciences was founded in 2015 by Jon Vaught, Nick Hofmeister, and Christopher Zalewski.
Front Range Biosciences has raised $53.0M across 5 funding rounds.
Front Range Biosciences has raised $53.0M in total across 5 funding rounds.
Front Range Biosciences has raised $53.0M in total across 5 funding rounds.
Front Range Biosciences's investors include Tiby Erdely, AFI Capital Partners, Arcadian Capital Management, Halley Venture Partners, Harvard Business School Alumni Angels of New York, Militello Capital, New York Angels, Phyto Partners, Salveo Capital, Sand Hill Angels, Vikas Desai, Altitude Investment Management.
Front Range Biosciences has raised $53.0M across 5 funding rounds. Most recently, it raised $30.0M Series B in August 2020.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Aug 27, 2020 | $30M Series B | Tiby Erdely | — | Announced |
| Sep 16, 2019 | $8.5M Venture Round | — | AFI Capital Partners, Arcadian Capital Management, Halley Venture Partners, Harvard Business School Alumni Angels OF NEW York, Militello Capital, NEW York Angels, Phyto Partners, Salveo Capital, Sand Hill Angels, Vikas Desai | Announced |
| Oct 4, 2018 | $10M Series A | — | Altitude Investment Management, Cornerstone Opportunity Partners, Harvard Business School Alumni Angels OF NEW York, NEW York Angels, Larry Schnurmacher, Michael Gruber, Sand Hill Angels, Vikas Desai | Announced |
| Sep 20, 2017 | $3M Venture Round | — | Anthill Ventures, Micah Tapman, Halley Venture Partners, Harvard Business School Angels, NEW York Angels, Brett Finkelstein, Salveo Capital, Sand Hill Angels | Announced |
| Feb 23, 2017 | $1.5M Seed | — | Harvard Business School Alumni Angels OF NEW York, Intuitive Private Equity, NEW York Angels, Salveo Capital, Sand Hill Angels | Announced |